On July 24, 2023, the Board of Directors of Interpace Biosciences, Inc. appointed Christopher McCarthy, age 32,as Chief Financial Officer. Mr. McCarthy has served as the Company?s Principal Financial Officer since April 2023. Prior to serving as the Company?s Principal Financial Officer, Mr. McCarthy served as the Company?s Vice President of Finance and Enterprise Systems from August 2022 to April 2023, Senior Director of Operations Finance from August 2020 to August 2022 and the Company?s Senior Financial Analyst from June 2019 to August 2020.

Prior to joining the Company, Mr. McCarthy served as a Senior Financial Systems Analyst at Simon & Schuster, Inc. from January 2016 to June 2019.